Inovio Pharmaceuticals (INO) Capital Expenditures (2010 - 2025)

Inovio Pharmaceuticals (INO) posted Capital Expenditures of $127444.0 for Q4 2025, up 39.19% sequentially from $91564.0 in Q3 2025.

Inovio Pharmaceuticals (INO) Capital Expenditures (2010 - 2025) Analysis & Trends

Inovio Pharmaceuticals has reported Capital Expenditures for 16 years, with the latest figure at $127444.0 in Q4 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $127444.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $226325.0 (up 117.14% YoY) and the FY2025 annual result came in at $285698.0, down 41.44% from the prior year.
Capital Expenditures grew to $127444.0 in Q4 2025 per INO's latest filing, from $91564.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $487832.0 in Q3 2024 and troughed at -$695863.0 in Q4 2022.
A 5-year average of $87964.0 and a median of $148029.0 in 2021 frame the typical range for Capital Expenditures.
The sharpest annual moves came in 2021 and 2024: Capital Expenditures jumped 484.31% in 2021, then sank 238.04% in 2024.
Over 5 years, Capital Expenditures stood at -$382533.0 in 2021, then slumped by 81.91% to -$695863.0 in 2022, then soared by 146.12% to $320898.0 in 2023, then soared by 52.02% to $487832.0 in 2024, then plunged by 73.88% to $127444.0 in 2025.
According to Business Quant data, Capital Expenditures over the past three periods registered $127444.0, $91564.0, and $7317.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	25.02 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	34.68 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-73.57 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	6.26 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	251.02 Mn
10	Inovio Pharmaceuticals	96.32 Mn	96.32 Mn	-	-

Download Data